In Memoriam – Larry Kramer
Treatment Action Group (TAG) is deeply saddened to learn that the seemingly indestructible writer, activist, playwright, and agitator Larry Kramer has died at 84.
Long-Acting Injectable Cabotegravir for HIV Pre-Exposure Prophylaxis (PrEP): Promising Results from HPTN 083
Treatment Action Group (TAG) welcomes the news that long-acting injectable cabotegravir (CAB LA, from ViiV Healthcare) demonstrated a high level of efficacy for preventing HIV infection in cisgender men and transgender women who have sex with men in the HIV Prevention Trials Network (HPTN) 083 trial.
Appeal to UAE Authorities to Release Prisoners with HIV Vulnerable to COVID-19
On May 18th, TAG and 46 other organizations and individuals – including the Stop TB Partnership, Global Coalition of TB Activists, and regional networks of people living with HIV, people affected by TB, and people who use drugs – are sending this letter to authorities in the United Arab Emirates (UAE) with an urgent appeal concerning the health of people with HIV in UAE prisons who are vulnerable to COVID-19.
SARS-CoV-2 Serological Testing: What Is It and What Does It Mean?
ICAP at Columbia, TAG, and the COVID-19 Working Group – New York presented this webinar on May 13, 2020.
AVAC and TAG Statement on Ethical Conduct of SARS-CoV-2 Vaccine Challenge Studies
The COVID-19 pandemic is a global health emergency that may demand new, safe, and expedited ways of conducting ethical research to find the solutions we need, including a safe and effective vaccine.
TAGline May 2020
Realizing the Right to Science: When we started to put together this issue of TAGline, we had no idea that COVID-19 was about to make its appearance and wreak havoc on every country of the world.
Treatment Action Group and the PrEP4All Collaboration Respond to Reported Remdesivir Results for COVID-19
Treatment Action Group (TAG) and the PrEP4All Collaboration welcome results from randomized controlled trials of therapies for COVID-19, but are seriously concerned about claims that data from a National Institutes of Allergy and Infectious Diseases (NIAID) study of the Gilead drug remdesivir...
In This Together: Virtual End the Epidemic Town Hall
On Friday April 24th, 2020 ANEA hosted a virtual gathering for HIV/AIDS community organizations and leaders involved in "Ending the Epidemic" state, local, or community initiatives that are experiencing disruptions from the COVID-19 pandemic.
Open Letter to the Diagnostics Supply Consortium
On 24 April 2020, advocates sent an open letter to the Diagnostics Supply Consortium calling for a higher level of global coordination, transparency, and accountability to ensure sustainable and equitable access to molecular diagnostic testing for COVID-19...
Global Health and Human Rights Organizations Denounce Trump Administration Decision to Pull Commitments to WHO during COVID-19 Crisis
AVAC, Health GAP, Knowledge Ecology International (KEI), and Treatment Action Group (TAG) strongly condemn the Trump Administration’s decision to halt funding to the World Health Organization (WHO) in the midst of the urgent COVID-19 global health crisis.